About Index Trending news
Analyze
Pricing
bioTheranostics

bioTheranostics

Work at bioTheranostics? Add yourself to this profile

bioTheranostics

Biotheranostics discovers and develops proprietary molecularbased tests that provide physicians with actionable information to help guide cancer treatment..

Elsewhere

Alexa global traffic share

22 Jan 2016
$32,000,000
Private equity
HealthQuest Capital, MVM Life Science Partners, Canepa Advanced Healthcare Fund

BioTheranostics, Acquired in 2008, To Go Independent in $32M Deal

Xconomy